YAP1 and cancer: A genome-wide chromatin mapping integrated with proteomics across different YAP-driven cancer types would be useful for uncovering novel regulators of YAP/TAZ-mediated transcriptional control networks, and this information can be leveraged for new therapeutic interventions.